Skip to content

Author

Dan Matuszek

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

rAAV production cost analysis: Indication-specific cost per dose and reduction strategies

The first comprehensive, platform-resolved cost analysis of rAAV production across three industrially relevant suspension platforms is presented, suggesting the potential for improved supply feasibility, even for high-dose neuromuscular indications, under the modeled assumptions of productivity improvement and process...

Min Tae Park, Dan Matuszek, A. Andaluz et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.